These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24860847)

  • 21. Chimeric capsid protein as a nanocarrier for siRNA delivery: stability and cellular uptake of encapsulated siRNA.
    Choi KM; Choi SH; Jeon H; Kim IS; Ahn HJ
    ACS Nano; 2011 Nov; 5(11):8690-9. PubMed ID: 21985460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein micro- and nano-capsules for biomedical applications.
    Shimanovich U; Bernardes GJ; Knowles TP; Cavaco-Paulo A
    Chem Soc Rev; 2014 Mar; 43(5):1361-71. PubMed ID: 24336689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbohydrate nanocarriers in biomedical applications: functionalization and construction.
    Kang B; Opatz T; Landfester K; Wurm FR
    Chem Soc Rev; 2015 Nov; 44(22):8301-25. PubMed ID: 26278884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA nanostructure-based imaging probes and drug carriers.
    Zhan P; Jiang Q; Wang ZG; Li N; Yu H; Ding B
    ChemMedChem; 2014 Sep; 9(9):2013-20. PubMed ID: 25045126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Peptide aptamers and nano-carriers for cancer therapy].
    Shiba K
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):362-5. PubMed ID: 19295259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics.
    Lee NK; Lee EJ; Kim S; Nam GH; Kih M; Hong Y; Jeong C; Yang Y; Byun Y; Kim IS
    J Control Release; 2017 Dec; 267():172-180. PubMed ID: 28821462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly organized nanostructures for brain drug delivery--new hope or just a fad?
    Labuzek K; Gorki K; Jaroszek H; Jarzabek K; Gabryel B; Okopien B
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1271-85. PubMed ID: 24040789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-assembling protein nanocages for modular enzyme assembly by orthogonal bioconjugation.
    Berckman EA; Chen W
    Biotechnol Prog; 2021 Sep; 37(5):e3190. PubMed ID: 34173352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferritin Nanocages for Protein Delivery to Tumor Cells.
    Palombarini F; Di Fabio E; Boffi A; Macone A; Bonamore A
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32070033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent trends in drug delivery system using protein nanoparticles.
    Sripriyalakshmi S; Jose P; Ravindran A; Anjali CH
    Cell Biochem Biophys; 2014 Sep; 70(1):17-26. PubMed ID: 24668188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanodiamond-insulin complexes as pH-dependent protein delivery vehicles.
    Shimkunas RA; Robinson E; Lam R; Lu S; Xu X; Zhang XQ; Huang H; Osawa E; Ho D
    Biomaterials; 2009 Oct; 30(29):5720-8. PubMed ID: 19635632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics.
    Gu L; Faig A; Abdelhamid D; Uhrich K
    Acc Chem Res; 2014 Oct; 47(10):2867-77. PubMed ID: 25141069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
    Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
    J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microfluidics: a focus on improved cancer targeted drug delivery systems.
    Khan IU; Serra CA; Anton N; Vandamme T
    J Control Release; 2013 Dec; 172(3):1065-74. PubMed ID: 23933524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-viral nanosystems for systemic siRNA delivery.
    David S; Pitard B; Benoît JP; Passirani C
    Pharmacol Res; 2010 Aug; 62(2):100-14. PubMed ID: 20006707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanostructured lipid carriers (NLCs) for drug delivery and targeting.
    Fang CL; Al-Suwayeh SA; Fang JY
    Recent Pat Nanotechnol; 2013 Jan; 7(1):41-55. PubMed ID: 22946628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of polymeric nanostructure shape on drug delivery.
    Venkataraman S; Hedrick JL; Ong ZY; Yang C; Ee PL; Hammond PT; Yang YY
    Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1228-46. PubMed ID: 21777633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications and advancements of polysaccharide-based nanostructures for enhanced drug delivery.
    Kareemi AF; Likhitkar S
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113883. PubMed ID: 38615389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface-functionalized nanoparticles for controlled drug delivery.
    Choi SW; Kim WS; Kim JH
    Methods Mol Biol; 2005; 303():121-31. PubMed ID: 15923680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells.
    Toita R; Murata M; Abe K; Narahara S; Piao JS; Kang JH; Hashizume M
    Chem Commun (Camb); 2013 Aug; 49(67):7442-4. PubMed ID: 23860596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.